×
About 110,833 results

ALLMedicine™ Lung Cancer Center

Research & Reviews  37,697 results

Annual Report to the Nation: Rapid Decrease in Lung Cancer and Melanoma Deaths Lead Overall Continued Decline in Cancer Death Rate
http://pressroom.cancer.org/ARN2021
American Cancer Society

Jul 8th, 2021 - Overall cancer death rates continue to decline in men and women for all racial and ethnic groups in the United States, according to the latest Annual Report to the Nation on the Status of Cancer. During 2001 to 2018, declines in lung cancer death ...

Screening for Lung Cancer
https://www.aafp.org/afp/2021/0700/p79.html
American Family Physician; Tracer H, Pierre J.

Jul 7th, 2021 - S.J., a 68-year-old Black man, comes to your office to establish care after recently moving to the area. S.J. has a history of allergic rhinitis, osteoarthritis, and gastroesophageal reflux disease. Additionally, he has a 39-pack-year history of s...

Quercetin Inhibits the Epithelial to Mesenchymal Transition through Suppressing Akt Med...
https://doi.org/10.1080/01635581.2021.1957487
Nutrition and Cancer; Elumalai P, Ezhilarasan D et. al.

Aug 3rd, 2021 - Lung cancer is a first leading cause of cancer related death worldwide. Quercetin (QUE) has chemo-preventive effect against a variety of cancers. However, the molecular mechanism of QUE mediated inhibition of cancer cell migration and epithelial t...

Inhibition of human lung cancer cells by anti-p21Ras scFv mediated by the activatable c...
https://doi.org/10.1097/CAD.0000000000001180
Anti-cancer Drugs; Du Y, Lin X et. al.

Aug 3rd, 2021 - Activatable cell-penetrating peptide (ACPP) is a tumour-targeting cell-penetrating peptide. Here, we used ACPP to carry anti-p21Ras scFv for Ras-driven cancer therapy. The ACPP-p21Ras scFv fusion protein was prepared by a prokaryotic expression sy...

Radiopaque Recreations of Lung Pathologies From Clinical Computed Tomography Images Usi...
https://doi.org/10.1097/RTI.0000000000000607
Journal of Thoracic Imaging; Wang J, Falkson SR et. al.

Aug 3rd, 2021 - The purpose of this study was to develop a 3-dimensional (3D) printing method to create computed tomography (CT) realistic phantoms of lung cancer nodules and lung parenchymal disease from clinical CT images. Low-density paper was used as substrat...

see more →

Guidelines  81 results

Annual Report to the Nation: Rapid Decrease in Lung Cancer and Melanoma Deaths Lead Overall Continued Decline in Cancer Death Rate
http://pressroom.cancer.org/ARN2021
American Cancer Society

Jul 8th, 2021 - Overall cancer death rates continue to decline in men and women for all racial and ethnic groups in the United States, according to the latest Annual Report to the Nation on the Status of Cancer. During 2001 to 2018, declines in lung cancer death ...

Screening for Lung Cancer
https://www.aafp.org/afp/2021/0700/p79.html
American Family Physician; Tracer H, Pierre J.

Jul 7th, 2021 - S.J., a 68-year-old Black man, comes to your office to establish care after recently moving to the area. S.J. has a history of allergic rhinitis, osteoarthritis, and gastroesophageal reflux disease. Additionally, he has a 39-pack-year history of s...

Screening for Lung Cancer: CHEST Guideline and Expert Panel Report - Executive Summary.
https://doi.org/10.1016/j.chest.2021.07.003
Chest Mazzone PJ, Silvestri GA et. al.

Jul 17th, 2021 - Low-dose chest CT screening for lung cancer has become a standard of care in the United States, in large part due to the results of the National Lung Screening Trial. Additional evidence supporting the net benefit of low-dose chest CT screening fo...

Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
https://doi.org/10.1016/j.chest.2021.06.063
Chest Mazzone PJ, Silvestri GA et. al.

Jul 17th, 2021 - Low-dose chest CT screening for lung cancer has become a standard of care in the United States, in large part due to the results of the National Lung Screening Trial. Additional evidence supporting the net benefit of low-dose chest CT screening fo...

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and ...
https://doi.org/10.1016/j.annonc.2021.03.207
Annals of Oncology : Official Journal of the European Soc... Dingemans AC, Früh M et. al.

Apr 18th, 2021 - Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆.|2021|Dingemans AC,Früh M,Ardizzoni A,Besse B,Faivre-Finn C,|

see more →

Drugs  199 results see all →

Clinicaltrials.gov  2,764 results

Annual Report to the Nation: Rapid Decrease in Lung Cancer and Melanoma Deaths Lead Overall Continued Decline in Cancer Death Rate
http://pressroom.cancer.org/ARN2021
American Cancer Society

Jul 8th, 2021 - Overall cancer death rates continue to decline in men and women for all racial and ethnic groups in the United States, according to the latest Annual Report to the Nation on the Status of Cancer. During 2001 to 2018, declines in lung cancer death ...

Screening for Lung Cancer
https://www.aafp.org/afp/2021/0700/p79.html
American Family Physician; Tracer H, Pierre J.

Jul 7th, 2021 - S.J., a 68-year-old Black man, comes to your office to establish care after recently moving to the area. S.J. has a history of allergic rhinitis, osteoarthritis, and gastroesophageal reflux disease. Additionally, he has a 39-pack-year history of s...

Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer
https://clinicaltrials.gov/ct2/show/NCT02546986

May 7th, 2020 - This is a Phase 2, multicenter, international, randomized, placebo controlled, double-blind study to assess the safety and efficacy of CC-486 and pembrolizumab combination therapy versus pembrolizumab plus placebo in previously treated patients wi...

MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC
https://clinicaltrials.gov/ct2/show/NCT02592577

May 7th, 2020 - This first time in human study is intended for men and women at least 18 years of age who have advanced lung cancer which has grown or returned after being treated. In particular, it is a study for subjects who have a blood test positive for HLA-A...

A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China
https://clinicaltrials.gov/ct2/show/NCT00559065

May 6th, 2020 - Benzene is a known leukemogen and may cause lymphoma as well, but its ability to , cause these conditions below 10 parts per million (ppm) in air are unclear. It is currently regulated in the United States at 1 ppm as an 8-hour time-weighted avera...

see more →

News  3,545 results

Annual Report to the Nation: Rapid Decrease in Lung Cancer and Melanoma Deaths Lead Overall Continued Decline in Cancer Death Rate
http://pressroom.cancer.org/ARN2021
American Cancer Society

Jul 8th, 2021 - Overall cancer death rates continue to decline in men and women for all racial and ethnic groups in the United States, according to the latest Annual Report to the Nation on the Status of Cancer. During 2001 to 2018, declines in lung cancer death ...

Screening for Lung Cancer
https://www.aafp.org/afp/2021/0700/p79.html
American Family Physician; Tracer H, Pierre J.

Jul 7th, 2021 - S.J., a 68-year-old Black man, comes to your office to establish care after recently moving to the area. S.J. has a history of allergic rhinitis, osteoarthritis, and gastroesophageal reflux disease. Additionally, he has a 39-pack-year history of s...

NSCLC and Melanoma Lead Continuing Fall in US Cancer Death Rates
https://www.medscape.com/viewarticle/954760

Jul 14th, 2021 - Cancer death rates in the United States continue to decline overall for many common cancers. This decline is particularly prounounced for non–small cell lung cancer (NSCLC) and melanoma, according to the latest statistics in the "Annual Report to ...

Screening Could Reduce Lung Cancer Deaths by One Quarter
https://www.medscape.com/viewarticle/954782

Jul 14th, 2021 - Lung cancer remains the leading cause of cancer deaths worldwide, with nearly 2 million fatalities per year, but these deaths could be reduced by a quarter with more targeted lung screening, argues a new report. Screening of high-risk individuals ...

Latest FDA Pembrolizumab Approval Expands Label to Cutaneous SCCs
https://www.medscape.com/viewarticle/954715

Jul 13th, 2021 - The Food and Drug Administration has approved pembrolizumab (Keytruda) monotherapy for locally advanced cutaneous squamous cell carcinoma (cSCC) that can't be cured by surgery or radiation. The July 6 approval for the programmed death–1 inhibitor ...

see more →

Patient Education  47 results see all →